Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement
Journal of the Advanced Practitioner in Oncology · 26.06.2026 · 17 (7)
DOI: 10.6004/jadpro.2026.17.7.21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 26.06.2026. Verfasst von Yue Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: From Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Palmar-plantar erythrodysesthesia, also known as hand-foot syndrome (HFS), is a common dermatologic toxicity of capecitabine. In this report, the case of a 59-year-old man with metastatic pancreatic ductal adenocarcinoma who developed grade 2 HFS with rare genital involvement is described. This case underscores the importance of recognizing atypical genital involvement in HFS to support timely management.
Autor:innen und Institutionen
- From Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.
Zitieren
APA
Feng, Y., Baroody, C., & Al Mutar, S. (2026). Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.21
Vancouver
Feng Y, Baroody C, Al Mutar S. Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.21
BibTeX
@article{Feng2026,
author = {Feng, Yue and Baroody, Christina and Al Mutar, Salwan},
title = {Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.6004/jadpro.2026.17.7.21}
}
EUVIMED